ID   IL2_MOUSE               Reviewed;         169 AA.
AC   P04351; P97945; Q791T3;
DT   20-MAR-1987, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-1987, sequence version 1.
DT   03-AUG-2022, entry version 187.
DE   RecName: Full=Interleukin-2;
DE            Short=IL-2;
DE   AltName: Full=T-cell growth factor;
DE            Short=TCGF;
DE   Flags: Precursor;
GN   Name=Il2; Synonyms=Il-2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=BALB/cJ;
RX   PubMed=6240025; DOI=10.1093/nar/12.24.9323;
RA   Fuse A., Fujita T., Yasumitsu H., Kashima N., Hasegawa K., Taniguchi T.;
RT   "Organization and structure of the mouse interleukin-2 gene.";
RL   Nucleic Acids Res. 12:9323-9331(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=B10BR;
RX   PubMed=2578624; DOI=10.1038/313402a0;
RA   Kashima N., Nishi-Takaoka C., Fujita T., Taki S., Yamada G., Hamuro J.,
RA   Taniguchi T.;
RT   "Unique structure of murine interleukin-2 as deduced from cloned cDNAs.";
RL   Nature 313:402-404(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=3918306; DOI=10.1073/pnas.82.1.68;
RA   Yokota T., Arai N., Lee F., Rennick D., Mosmann T., Arai K.;
RT   "Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA
RT   clones: expression of T-cell growth-factor activity after transfection of
RT   monkey cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:68-72(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3003564; DOI=10.1007/bf00417597;
RA   Degrave W., Simons G., Devos R., Plaetinck G., Remaut E., Tavernier J.,
RA   Fiers W.;
RT   "Cloning and structure of a mouse interleukin-2 chromosomal gene.";
RL   Mol. Biol. Rep. 11:57-61(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=10779485; DOI=10.1101/gr.10.4.446;
RA   Lyons P.A., Armitage N., Argentina F., Denny P., Hill N.J., Lord C.J.,
RA   Wilusz M.B., Peterson L.B., Wicker L.S., Todd J.A.;
RT   "Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of
RT   mouse chromosome 3: identification of a candidate segment of ancestral DNA
RT   by haplotype mapping.";
RL   Genome Res. 10:446-453(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Spleen;
RA   Ma R.Z., Teuscher C.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-63.
RC   STRAIN=RF; TISSUE=Spleen;
RX   PubMed=1420317; DOI=10.1016/0167-4781(92)90174-x;
RA   Matesanz F., Alcina A., Pellicer A.;
RT   "A new cDNA sequence for the murine interleukin-2 gene.";
RL   Biochim. Biophys. Acta 1132:335-336(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-63.
RC   STRAIN=CAST/EiJ, and RF/J; TISSUE=Spleen;
RX   PubMed=8319981; DOI=10.1007/bf00188809;
RA   Matesanz F., Alcina A., Pellicer A.;
RT   "Existence of at least five interleukin-2 molecules in different mouse
RT   strains.";
RL   Immunogenetics 38:300-303(1993).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=9814585; DOI=10.1155/1998/19567;
RA   Reya T., Bassiri H., Biancaniello R., Carding S.R.;
RT   "Thymic stromal-cell abnormalities and dysregulated T-cell development in
RT   IL-2-deficient mice.";
RL   Dev. Immunol. 5:287-302(1998).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION BY DENDRITIC CELLS.
RX   PubMed=11526406; DOI=10.1038/ni0901-882;
RA   Granucci F., Vizzardelli C., Pavelka N., Feau S., Persico M., Virzi E.,
RA   Rescigno M., Moro G., Ricciardi-Castagnoli P.;
RT   "Inducible IL-2 production by dendritic cells revealed by global gene
RT   expression analysis.";
RL   Nat. Immunol. 2:882-888(2001).
RN   [12]
RP   FUNCTION.
RX   PubMed=14614860; DOI=10.1016/s1074-7613(03)00292-9;
RA   Zhu J., Cote-Sierra J., Guo L., Paul W.E.;
RT   "Stat5 activation plays a critical role in Th2 differentiation.";
RL   Immunity 19:739-748(2003).
RN   [13]
RP   FUNCTION.
RX   PubMed=27018889; DOI=10.1038/nchembio.2056;
RA   Smith G.A., Uchida K., Weiss A., Taunton J.;
RT   "Essential biphasic role for JAK3 catalytic activity in IL-2 receptor
RT   signaling.";
RL   Nat. Chem. Biol. 12:373-379(2016).
RN   [14]
RP   3D-STRUCTURE MODELING.
RX   PubMed=8262055; DOI=10.1002/j.1460-2075.1993.tb06206.x;
RA   Zurawski S., Vega F. Jr., Doyel E.L., Huyghe B., Flaherty K., McKay D.B.,
RA   Zurawski G.;
RT   "Definition and spatial location of mouse interleukin-2 residues that
RT   interact with its heterotrimeric receptor.";
RL   EMBO J. 12:5113-5119(1993).
RN   [15] {ECO:0007744|PDB:4YQX, ECO:0007744|PDB:4YUE}
RP   X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 47-169, AND DISULFIDE BOND.
RX   PubMed=25992858; DOI=10.1016/j.immuni.2015.04.015;
RA   Spangler J.B., Tomala J., Luca V.C., Jude K.M., Dong S., Ring A.M.,
RA   Votavova P., Pepper M., Kovar M., Garcia K.C.;
RT   "Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation
RT   through Distinct Conformational Mechanisms.";
RL   Immunity 42:815-825(2015).
CC   -!- FUNCTION: Cytokine produced by activated CD4-positive helper T-cells
CC       and to a lesser extend activated CD8-positive T-cells and natural
CC       killer (NK) cells that plays pivotal roles in the immune response and
CC       tolerance (PubMed:9814585, PubMed:14614860). Binds to a receptor
CC       complex composed of either the high-affinity trimeric IL-2R
CC       (IL2RA/CD25, IL2RB/CD122 and IL2RG/CD132) or the low-affinity dimeric
CC       IL-2R (IL2RB and IL2RG). Interaction with the receptor leads to
CC       oligomerization and conformation changes in the IL-2R subunits
CC       resulting in downstream signaling starting with phosphorylation of JAK1
CC       and JAK3. In turn, JAK1 and JAK3 phosphorylate the receptor to form a
CC       docking site leading to the phosphorylation of several substrates
CC       including STAT5 (PubMed:14614860, PubMed:27018889). This process leads
CC       to activation of several pathways including STAT, phosphoinositide-3-
CC       kinase/PI3K and mitogen-activated protein kinase/MAPK pathways.
CC       Functions as a T-cell growth factor and can increase NK-cell cytolytic
CC       activity as well. Promotes strong proliferation of activated B-cells
CC       and subsequently immunoglobulin production. Plays a pivotal role in
CC       regulating the adaptive immune system by controlling the survival and
CC       proliferation of regulatory T-cells, which are required for the
CC       maintenance of immune tolerance (PubMed:14614860). Moreover,
CC       participates in the differentiation and homeostasis of effector T-cell
CC       subsets, including Th1, Th2, Th17 as well as memory CD8-positive T-
CC       cells (PubMed:9814585). {ECO:0000250|UniProtKB:P60568,
CC       ECO:0000269|PubMed:9814585}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Produced by immune cells including dendritic cells.
CC       In contrast, macrophages do not produce IL2 upon bacterial stimulation.
CC       {ECO:0000269|PubMed:11526406}.
CC   -!- INDUCTION: By bacterial infection. {ECO:0000269|PubMed:11526406}.
CC   -!- POLYMORPHISM: The poly-Gln region is highly polymorphic. {ECO:0000305}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice exhibit lethal autoimmunity and are
CC       impaired in regulatory T-cell production. After 4 to 5 weeks of birth,
CC       they develop a thymic disorder resulting in the disruption of thymocyte
CC       maturation. {ECO:0000269|PubMed:9814585}.
CC   -!- SIMILARITY: Belongs to the IL-2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X01663; CAA25823.1; -; Genomic_DNA.
DR   EMBL; X01664; CAA25824.1; -; Genomic_DNA.
DR   EMBL; X01665; CAA25825.1; -; Genomic_DNA.
DR   EMBL; X01772; CAA25909.1; -; mRNA.
DR   EMBL; K02292; AAA39289.1; -; mRNA.
DR   EMBL; M16762; AAA39281.1; -; Genomic_DNA.
DR   EMBL; M16760; AAA39281.1; JOINED; Genomic_DNA.
DR   EMBL; M16761; AAA39281.1; JOINED; Genomic_DNA.
DR   EMBL; AF195956; AAF32272.1; -; Genomic_DNA.
DR   EMBL; AF065914; AAD25890.1; -; mRNA.
DR   EMBL; AL662823; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X66058; CAA46854.1; -; mRNA.
DR   EMBL; L07574; AAA39326.1; -; Genomic_DNA.
DR   EMBL; L07576; AAA39328.1; -; Genomic_DNA.
DR   CCDS; CCDS17316.1; -.
DR   PIR; A93550; ICMS2.
DR   PIR; I54512; I54512.
DR   PIR; I68871; I68871.
DR   RefSeq; NP_032392.1; NM_008366.3.
DR   PDB; 4YQX; X-ray; 2.83 A; A/M=47-169.
DR   PDB; 4YUE; X-ray; 2.19 A; C=47-169.
DR   PDBsum; 4YQX; -.
DR   PDBsum; 4YUE; -.
DR   AlphaFoldDB; P04351; -.
DR   SMR; P04351; -.
DR   IntAct; P04351; 1.
DR   STRING; 10090.ENSMUSP00000029275; -.
DR   BindingDB; P04351; -.
DR   ChEMBL; CHEMBL2466; -.
DR   GlyGen; P04351; 1 site.
DR   PhosphoSitePlus; P04351; -.
DR   PaxDb; P04351; -.
DR   PRIDE; P04351; -.
DR   ABCD; P04351; 2 sequenced antibodies.
DR   Antibodypedia; 4147; 2022 antibodies from 47 providers.
DR   DNASU; 16183; -.
DR   Ensembl; ENSMUST00000029275; ENSMUSP00000029275; ENSMUSG00000027720.
DR   GeneID; 16183; -.
DR   KEGG; mmu:16183; -.
DR   UCSC; uc008pai.3; mouse.
DR   CTD; 3558; -.
DR   MGI; MGI:96548; Il2.
DR   VEuPathDB; HostDB:ENSMUSG00000027720; -.
DR   eggNOG; ENOG502RVR5; Eukaryota.
DR   GeneTree; ENSGT00390000003555; -.
DR   HOGENOM; CLU_124210_0_0_1; -.
DR   InParanoid; P04351; -.
DR   OMA; NGVNNYE; -.
DR   OrthoDB; 1491449at2759; -.
DR   PhylomeDB; P04351; -.
DR   TreeFam; TF338200; -.
DR   BioGRID-ORCS; 16183; 2 hits in 113 CRISPR screens.
DR   ChiTaRS; Il2; mouse.
DR   PRO; PR:P04351; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; P04351; protein.
DR   Bgee; ENSMUSG00000027720; Expressed in chordate pharynx and 15 other tissues.
DR   Genevisible; P04351; MM.
DR   GO; GO:0005615; C:extracellular space; IDA:MGI.
DR   GO; GO:0030246; F:carbohydrate binding; ISO:MGI.
DR   GO; GO:0005125; F:cytokine activity; IDA:MGI.
DR   GO; GO:0043208; F:glycosphingolipid binding; ISO:MGI.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005134; F:interleukin-2 receptor binding; IDA:MGI.
DR   GO; GO:0031851; F:kappa-type opioid receptor binding; ISO:MGI.
DR   GO; GO:0050798; P:activated T cell proliferation; IDA:MGI.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IDA:MGI.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:MGI.
DR   GO; GO:0010467; P:gene expression; IDA:MGI.
DR   GO; GO:0002366; P:leukocyte activation involved in immune response; ISO:MGI.
DR   GO; GO:0046651; P:lymphocyte proliferation; IMP:MGI.
DR   GO; GO:0002903; P:negative regulation of B cell apoptotic process; ISO:MGI.
DR   GO; GO:0045822; P:negative regulation of heart contraction; ISO:MGI.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IMP:MGI.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; IMP:MGI.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:MGI.
DR   GO; GO:2000320; P:negative regulation of T-helper 17 cell differentiation; IGI:BHF-UCL.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IDA:MGI.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; ISO:MGI.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:MGI.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; ISO:MGI.
DR   GO; GO:0002639; P:positive regulation of immunoglobulin production; IMP:MGI.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IDA:MGI.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; ISO:MGI.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IMP:MGI.
DR   GO; GO:1900100; P:positive regulation of plasma cell differentiation; ISO:MGI.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:MGI.
DR   GO; GO:0045591; P:positive regulation of regulatory T cell differentiation; ISO:MGI.
DR   GO; GO:0045582; P:positive regulation of T cell differentiation; ISO:MGI.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IDA:MGI.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; ISO:MGI.
DR   GO; GO:2000561; P:regulation of CD4-positive, alpha-beta T cell proliferation; IMP:MGI.
DR   GO; GO:0046013; P:regulation of T cell homeostatic proliferation; IMP:MGI.
DR   GO; GO:0045471; P:response to ethanol; ISO:MGI.
DR   GO; GO:0042098; P:T cell proliferation; IDA:MGI.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0007260; P:tyrosine phosphorylation of STAT protein; IDA:MGI.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR000779; IL-2.
DR   InterPro; IPR030477; IL-2_CS.
DR   Pfam; PF00715; IL2; 1.
DR   PRINTS; PR00265; INTERLEUKIN2.
DR   SMART; SM00189; IL2; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00424; INTERLEUKIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Cytokine; Disulfide bond; Glycoprotein;
KW   Growth factor; Immunity; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..20
FT   CHAIN           21..169
FT                   /note="Interleukin-2"
FT                   /id="PRO_0000015493"
FT   CARBOHYD        23
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000250"
FT   DISULFID        92..140
FT                   /evidence="ECO:0000269|PubMed:25992858,
FT                   ECO:0007744|PDB:4YQX, ECO:0007744|PDB:4YUE"
FT   VARIANT         26
FT                   /note="S -> P (in strain: RF/J and CAST/Ei)"
FT   VARIANT         30
FT                   /note="S -> P (in strain: RF/J)"
FT   VARIANT         32..39
FT                   /note="AEAQQQQQ -> SSSTAEA (in strain: CAST/Ei)"
FT   VARIANT         32..38
FT                   /note="AEAQQQQ -> SSSTAEA (in strain: RF/J)"
FT   CONFLICT        108
FT                   /note="Q -> E (in Ref. 4; AAA39281)"
FT                   /evidence="ECO:0000305"
FT   HELIX           47..60
FT                   /evidence="ECO:0007829|PDB:4YUE"
FT   HELIX           70..73
FT                   /evidence="ECO:0007829|PDB:4YQX"
FT   STRAND          75..79
FT                   /evidence="ECO:0007829|PDB:4YQX"
FT   HELIX           87..90
FT                   /evidence="ECO:0007829|PDB:4YUE"
FT   HELIX           91..94
FT                   /evidence="ECO:0007829|PDB:4YUE"
FT   HELIX           97..103
FT                   /evidence="ECO:0007829|PDB:4YUE"
FT   HELIX           118..132
FT                   /evidence="ECO:0007829|PDB:4YUE"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:4YQX"
FT   STRAND          144..148
FT                   /evidence="ECO:0007829|PDB:4YQX"
FT   HELIX           149..164
FT                   /evidence="ECO:0007829|PDB:4YUE"
SQ   SEQUENCE   169 AA;  19400 MW;  B3B17644F6EF83CA CRC64;
     MYSMQLASCV TLTLVLLVNS APTSSSTSSS TAEAQQQQQQ QQQQQQHLEQ LLMDLQELLS
     RMENYRNLKL PRMLTFKFYL PKQATELKDL QCLEDELGPL RHVLDLTQSK SFQLEDAENF
     ISNIRVTVVK LKGSDNTFEC QFDDESATVV DFLRRWIAFC QSIISTSPQ
//
